Pfizer plans to invest more than $2.5B to expand its drug manufacturing sites in Puurs, Belgium, and Dublin, Ireland, Reuters’ Michael Erman reports. "It is all aligned with the growth of our pipeline," Pfizer Chief Global Supply Officer Mike McDermott told Reuters. Pfizer hopes to introduce as many as 19 new medicines over the next year and a half, including treatments for ulcerative colitis and migraines, as well as its vaccine for RSV, the report notes. Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PFE:
- Twitter offers advertisers big incentives to boost spending, WSJ reports
- Carrick Therapeutics closes $25M Series C financing
- Carrick Therapeutics receives $35M investment from Pfizer
- Roivant Sciences, Pfizer form new Vant company focused on developing RVT-3101
- Pfizer call volume above normal and directionally bullish